SCHEMBL2876265

SCHEMBL2876265

CC(C)COC(=O)N1CCC(COc2ncc(-c3ccc(S(C)(=O)=O)cc3)cn2)CC1

nearest known ligand 0.56

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 17/20 0.56
GRIN2B Q13224 1/20 0.46
GPR183 P32249 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2883378 0.90 GPR119 (0.56) GPR119
SCHEMBL3844161 0.88 GPR119 (0.55) GPR119GPR183
SCHEMBL2881337 0.86 GPR119 (0.56) GPR119GPR183
SCHEMBL4464281 0.85 GRIN2B (0.58) GPR119GRIN2B
SCHEMBL4457000 0.85 PTGS2 (0.44) GPR119GRIN2BGPR183
SCHEMBL385210 0.84 GPR119 (0.61) GPR119
SCHEMBL2881232 0.84 GPR119 (0.61) GPR119GPR183
SCHEMBL4053229 0.84 GPR119 (0.61) GPR119GPR183
SCHEMBL3983386 0.82 GPR119 (0.56) GPR119GRIN2B
SCHEMBL2879359 0.82 GPR119 (0.52) GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2010512334-A 2010-04-22 JP claimed
EP-2094683-A2 BICYCLIC COMPOUNDS AND USE AS ANTIDIABETICS SmithKline Beecham Corporation (US) 2009-09-02 EP claimed
WO-2008070692-A2 BICYCLIC COMPOUNDS AND USE AS ANTIDIABETICS SMITHKLINE BEECHAM CORPORATION (US) 2008-06-12 WO claimed
EP-2094683-A2 BICYCLIC COMPOUNDS AND USE AS ANTIDIABETICS SmithKline Beecham Corporation (US) 2009-09-02 EP disclosed
WO-2008070692-A2 BICYCLIC COMPOUNDS AND USE AS ANTIDIABETICS SMITHKLINE BEECHAM CORPORATION (US) 2008-06-12 WO disclosed